Udayan Guha - 30 Jan 2026 Form 4 Insider Report for NextCure, Inc. (NXTC)

Reporting relationship: Chief Medical Officer
Issuer ticker: NXTC
Reported as of: 30 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Feb 2026, 16:07:20 UTC
Prior SEC filing: 06 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Steven P. Cobourn, as attorney-in-fact for Udayan Guha

Key filing fact

Udayan Guha filed Form 4 for NextCure, Inc. (NXTC) on 03 Feb 2026.

Key facts

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0002054923 Primary reporting owner

Relationship: Chief Medical Officer
Address: C/O NEXTCURE, INC., 9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE
Signature: /s/ Steven P. Cobourn, as attorney-in-fact for Udayan Guha
Signature date: 03 Feb 2026

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NXTC transaction Derivative

Award

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

One fourth of the option vests on January 30, 2027. The remainder vests in 36 monthly installments beginning on February 28, 2027.